This inventor holds 1 USPTO granted patent. Top assignee: Warner-Lambert Company. Active years: 2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002
Title: Michael Aviram: Innovator in Lipoprotein Oxidation Inhibition
Introduction
Michael Aviram is a notable inventor based in Halfa, Israel. He has made significant contributions to the field of biochemistry, particularly in the area of cardiovascular health. His work focuses on the inhibition of lipoprotein oxidation, which is crucial for preventing various vascular diseases.
Latest Patents
Aviram holds a patent for the "Inhibition of lipoprotein oxidation." This patent describes how hydroxylated derivatives of cholesterol-lowering agents can inhibit the oxidation of lipoproteins. This innovation is particularly useful for preventing the progression of atherogenesis and resultant vascular diseases, including heart attacks. He has 1 patent to his name.
Career Highlights
Michael Aviram has had a distinguished career, working at Warner-Lambert Company, where he has been able to apply his research in practical settings. His work has had a lasting impact on the understanding and treatment of cardiovascular diseases.
Collaborations
Throughout his career, Aviram has collaborated with esteemed colleagues such as Charles Larry Bisgaier and Roger Schofield Newton. These collaborations have further enriched his research and contributed to advancements in the field.
Conclusion
Michael Aviram's innovative work in the inhibition of lipoprotein oxidation has made significant strides in cardiovascular health. His contributions continue to influence the medical community and improve patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile